FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to obstetrics and gynaecology, and can be used to evaluate the effectiveness of treatment with intravenous immunoglobulins in patients with habitual miscarriage and circulation of anti-phospholipid antibodies. The expression of kisspeptin (KISS) is determined by immunohistochemical study of the placenta. The relative area of KISS expression is determined, calculated by the formula 
, wherein S(%) is the relative area of KISS expression, S positive is the value of the area of immunopositive KISS cells; S total is the value of the area of the preparation. If the relative area of KISS expression equals 35% or more, the treatment is confirmed to be effective.
EFFECT: possibility of accurate and reliable evaluation of the effectiveness of treatment with intravenous immunoglobulins in patients with habitual miscarriage and circulation of anti-phospholipid antibodies by determining the KISS expression in a immunohistochemical study of the placenta.
1 cl, 8 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSMENT OF EFFICIENCY OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2786456C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN FEMALE PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTI-PHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2775311C1 |
| METHOD FOR IMMUNOPATHOLOGICAL PLACENTAL INSUFFICIENCY SIMULATION | 2021 |
|
RU2763837C1 |
| METHOD FOR TREATMENT OF RECURRENT PREGNANCY LOSS RELATED TO RETROCHORIAL HEMATOMA | 2017 |
|
RU2668715C1 |
| DIAGNOSTIC TECHNIQUE FOR PREMATURE DETACHMENT OF NORMALLY LOCATED PLACENTA | 2015 |
|
RU2601625C1 |
| METHOD FOR PREDICTING PLACENTA GROWTH DURING PREGNANCY | 2018 |
|
RU2679641C1 |
| METHOD OF TREATING THREATENED MISCARRIAGE IN EARLY PREGNANCY | 2009 |
|
RU2393841C1 |
| METHOD FOR PREECLAMPSIA SEVERITY DIAGNOSTICS BASED ON EVALUATION OF DNA-RECOGNIZING DAI-1 RECEPTORS EXPRESSION IN PLACENTAL TISSUE | 2017 |
|
RU2641029C1 |
| METHOD OF ENDOMETRIAL DYSFUNCTION TREATMENT | 2017 |
|
RU2655538C1 |
| METHOD OF MANAGEMENT OF PREGNANCY WITH INFECTIOUS PATHOLOGY OF UROGENITAL TRACT | 2017 |
|
RU2649127C1 |
